Home > Healthcare > Pharmaceuticals > Finished Drug Form > Generic Oncology Drugs Market

Generic Oncology Drugs Market Share

Report ID: GMI4425
Published Date: May 2024
Report Format: PDF

Download Free Sample

Generic Oncology Drugs Market Share

The generic oncology drugs industry comprises intense competition driven by numerous players offering cost-effective alternatives to branded medications. Key factors influencing competition include pricing strategies, product quality, regulatory compliance, and distribution networks. In addition, the companies are continually focusing on innovation in manufacturing processes and strategic partnerships which are pivotal for sustaining competitiveness in this dynamic market landscape.

Generic Oncology Drugs Market Companies

Some of the prominent players operating in the generic oncology drugs industry include:

AbbVie Inc.
Apotex Inc.
AstraZeneca
Biocon Ltd.
Gland Pharma Limited
Incyte Corporation
Lupin Pharmaceuticals, Inc.
Mylan N.V.
Natco Pharma Ltd.
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Synthon Pharmaceuticals, Inc.
Teva Pharmaceuticals
Zydus Lifesciences Limited

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of generic oncology drugs was reached USD 26.9 billion in 2023 and is expected to register 5.8% CAGR from 2024 to 2032 owing to global rise in cancer cases, driven by factors such as aging demographics, shifts in lifestyle, and environmental influences.

Generic oncology drugs industry from the targeted drugs segment is expected to cross USD 16.1 billion by 2032, due to its ability to precisely target cancer cells, minimize harm to healthy tissue, and reduce side effects.

North America generic oncology drugs industry recorded USD 11.3 billion in 2023 due to increasing cancer cases, rising adoption of branded generics, expanding healthcare spending, widespread cancer screening, and availability of innovative treatments, in the region.

Incyte Corporation, Mylan N.V., Natco Pharma Ltd., Novartis Pharmaceuticals Corporation, Pfizer Inc., Regeneron Pharmaceuticals Inc., Synthon Pharmaceuticals, Inc., Teva Pharmaceuticals, and Zydus Lifesciences Limited, are some of the major generic oncology drugs companies worldwide.